Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter.
Nav1.5 sodium channels in macrophages in multiple sclerosis lesions.
Differential diagnosis for cervical spondylotic myelopathy: literature review.
Effects of Panax ginseng in Neurodegenerative Diseases.
Identification of protein networks involved in the disease course of experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.
Adherence to interferon β-1a therapy using an electronic self-injector in multiple sclerosis: a multicentre, single-arm, observational, phase IV study.
Whole-Brain Diffusion Tensor Imaging in Correlation to Visual-Evoked Potentials in Multiple Sclerosis: A Tract-Based Spatial Statistics Analysis.
Infectious causes of multiple sclerosis.
The unwavering commitment of regulatory T cells in the suppression of autoimmune encephalomyelitis: Another aspect of immune privilege in the CNS.
Fatigue in multiple sclerosis - A brief review.
Optic neuritis in a child with biotinidase deficiency: case report and literature review.
Progressive multiple sclerosis: The treatment gap.
Product Insert, Amiloride HCl Tablets
Safety, tolerability, and efficacy of orally administered cannabinoids in MS.
Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients.
Cyclophosphamide for multiple sclerosis.
Oligodendrocytes and the early multiple sclerosis lesion.
Myelin Basic Protein-Specific TCR/HLA-DRB5*01:01 Transgenic Mice Support the Etiologic Role of DRB5*01:01 in Multiple Sclerosis.
Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor.
Therapeutic effect of ghrelin in experimental autoimmune encephalomyelitis by inhibiting antigen-specific Th1/Th17 responses and inducing regulatory T cells.
Cerebrospinal fluid IL-1β correlates with cortical pathology load in multiple sclerosis at clinical onset.
Challenges and recommendations for obtaining chemical structures of industry-provided repurposing candidates.
De novo PMP2 mutations in families with type 1 Charcot-Marie-Tooth disease.
Pharmacokinetics of dalfampridine extended release 7.5-mg tablets in healthy subjects and individuals with mild and moderate renal impairment: An open-label study.
Influence of pregnancy on neuromyelitis optica spectrum disorder.

Pages